Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation
-
- Corey Smith
- Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia; and
-
- Naohiro Wakisaka
- Division of Otolaryngology, Graduate School of Medicine, Kanazawa University, Kanazawa, Japan
-
- Tania Crough
- Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia; and
-
- Jesse Peet
- Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia; and
-
- Tomokazu Yoshizaki
- Division of Otolaryngology, Graduate School of Medicine, Kanazawa University, Kanazawa, Japan
-
- Leone Beagley
- Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia; and
-
- Rajiv Khanna
- Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia; and
書誌事項
- 公開日
- 2009-06-11
- 資源種別
- journal article
- DOI
-
- 10.1182/blood-2009-02-203687
- 公開者
- American Society of Hematology
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>Activation of the nuclear factor–κB pathway by Epstein-Barr virus–encoded latent membrane protein-1 (LMP-1) leads to an up-regulation of the major histocompatibility complex class I antigen–processing pathway. Paradoxically, LMP-1 itself induces a subdominant CD8+ T-cell response and appears to have evolved to avoid immune recognition. Here we show that, although expression of LMP-1 in human cells dramatically enhanced the trans-presentation of CD8+ T-cell epitopes, cis-presentation of LMP-1–derived epitopes was severely impaired. Testing of a series of LMP-1 mutants revealed that deletion of the first transmembrane domain of LMP-1, which prevented self-aggregation, significantly enhanced cis-presentation of T-cell epitopes from this protein, whereas it lost its ability to up-regulate trans-presentation. Interestingly, we also found that cis-presentation of LMP-1 epitopes was rescued by blocking the proteasome function. Taken together, these results delineate a novel mechanism of immune evasion, which renders a virally encoded oncogene inaccessible to the conventional major histocompatibility complex class I pathway limiting its cis-presentation to effector cells.</jats:p>
収録刊行物
-
- Blood
-
Blood 113 (24), 6148-6152, 2009-06-11
American Society of Hematology
- Tweet
キーワード
- Antigen Presentation
- Epstein-Barr Virus Infections
- Herpesvirus 4, Human
- Proteasome Endopeptidase Complex
- Lymphoma, B-Cell
- Histocompatibility Antigens Class I
- Epitopes, T-Lymphocyte
- Uterine Cervical Neoplasms
- Nasopharyngeal Neoplasms
- Vaccinia virus
- CD8-Positive T-Lymphocytes
- Flow Cytometry
- Peptide Fragments
- Interferon-gamma
- Epstein-Barr Virus Nuclear Antigens
- Tumor Cells, Cultured
- Humans
- Female
- Protein Multimerization
- Cell Line, Transformed
詳細情報 詳細情報について
-
- CRID
- 1360004236757982720
-
- NII論文ID
- 10026216770
-
- ISSN
- 15280020
- 00064971
-
- PubMed
- 19372256
-
- 資料種別
- journal article
-
- データソース種別
-
- Crossref
- CiNii Articles
- KAKEN
- OpenAIRE